Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
International Journal of Sport Nutrition and Exercise Metabolism|October 7, 2004
Nutrient intakes and dietary behaviors of male and female collegiate athletesPamela S Hinton, Tiffany C Sanford, M Meghan Davidson, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 1, 1995
Insulin-like growth factor-I enhances immune response in dexamethasone-treated or surgically stressed rats maintained with total parenteral nutritionP S Hinton, C A Peterson, H C Lo, et al.
Applied Optics|February 29, 2008
Field-programmable smart-pixel arrays: design, VLSI implementation, and applicationsS S Sherif, S K Griebel, A Au, et al.
Journal of the American Academy of Audiology|May 24, 2022
Approaches to Treat Sensorineural Hearing Loss by Hair-Cell Regeneration: The Current State of Therapeutic Developments and Their Potential Impact on Audiological Clinical PracticeAshley S Hinton, Aizhen Yang-Hood, Angela D Schrader, et al.
Leukemia|July 16, 2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemiaJ E Lancet, F Ravandi, R M Ricklis, et al.
Stroke|September 10, 1998
Retrograde transvenous neuroperfusion: a back door treatment for strokeJ G Frazee, X Luo, G Luan, et al.
Leukemia|May 3, 2002
Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferationL D Cripe, V M Gelfanov, E A Smith, et al.
Metabolism: Clinical and Experimental|August 25, 2014
The effects of improved metabolic risk factors on bone turnover markers after 12 weeks of simvastatin treatment with or without exerciseJun Jiang, Leryn J Boyle, Catherine R Mikus, et al.
Molecular Nutrition & Food Research|May 4, 2006
Metabolism of Maillard reaction products by the human gut microbiota--implications for healthKieran M Tuohy, Davinia J S Hinton, Sarah J Davies, et al.
Bone Marrow Transplantation|May 22, 2024
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trialsC Ganzel, Y Wang, K Roopcharan, et al.
Pageof 10